BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25086373)

  • 1. Contrast agents for preclinical targeted X-ray imaging.
    Li X; Anton N; Zuber G; Vandamme T
    Adv Drug Deliv Rev; 2014 Sep; 76():116-133. PubMed ID: 25086373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new formulation of poly(MAOTIB) nanoparticles as an efficient contrast agent for in vivo X-ray imaging.
    Wallyn J; Anton N; Serra CA; Bouquey M; Collot M; Anton H; Weickert JL; Messaddeq N; Vandamme TF
    Acta Biomater; 2018 Jan; 66():200-212. PubMed ID: 29129788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications.
    Liu Y; Ai K; Lu L
    Acc Chem Res; 2012 Oct; 45(10):1817-27. PubMed ID: 22950890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodinated blood pool contrast media for preclinical X-ray imaging applications--a review.
    Hallouard F; Anton N; Choquet P; Constantinesco A; Vandamme T
    Biomaterials; 2010 Aug; 31(24):6249-68. PubMed ID: 20510444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodinated α-tocopherol nano-emulsions as non-toxic contrast agents for preclinical X-ray imaging.
    Li X; Anton N; Zuber G; Zhao M; Messaddeq N; Hallouard F; Fessi H; Vandamme TF
    Biomaterials; 2013 Jan; 34(2):481-91. PubMed ID: 23083930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle contrast-enhanced micro-CT: A preclinical tool for the 3D imaging of liver and spleen in longitudinal mouse studies.
    Liu CN; Morin J; Dokmanovich M; Bluette CT; Goldstein R; Manickam B; Bagi CM
    J Pharmacol Toxicol Methods; 2019; 96():67-77. PubMed ID: 30738209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micro-CT of rodents: state-of-the-art and future perspectives.
    Clark DP; Badea CT
    Phys Med; 2014 Sep; 30(6):619-34. PubMed ID: 24974176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold nanoparticles as contrast agents in x-ray imaging and computed tomography.
    Cole LE; Ross RD; Tilley JM; Vargo-Gogola T; Roeder RK
    Nanomedicine (Lond); 2015 Jan; 10(2):321-41. PubMed ID: 25600973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution of X-ray iodinated contrast agent in nano-emulsions is controlled by the chemical nature of the oily core.
    Attia MF; Anton N; Chiper M; Akasov R; Anton H; Messaddeq N; Fournel S; Klymchenko AS; Mély Y; Vandamme TF
    ACS Nano; 2014 Oct; 8(10):10537-50. PubMed ID: 25284066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution and Toxicity of X-Ray Iodinated Contrast Agent in Nano-emulsions in Function of Their Size.
    Attia MF; Anton N; Akasov R; Chiper M; Markvicheva E; Vandamme TF
    Pharm Res; 2016 Mar; 33(3):603-14. PubMed ID: 26511860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in micro-CT imaging of small animals.
    Clark DP; Badea CT
    Phys Med; 2021 Aug; 88():175-192. PubMed ID: 34284331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly-ε-caprolactone tungsten oxide nanoparticles as a contrast agent for X-ray computed tomography.
    Jakhmola A; Anton N; Anton H; Messaddeq N; Hallouard F; Klymchenko A; Mely Y; Vandamme TF
    Biomaterials; 2014 Mar; 35(9):2981-6. PubMed ID: 24393266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo small animal micro-CT using nanoparticle contrast agents.
    Ashton JR; West JL; Badea CT
    Front Pharmacol; 2015; 6():256. PubMed ID: 26581654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of dual- and triple-energy cone-beam micro-CT for postreconstruction material decomposition.
    Granton PV; Pollmann SI; Ford NL; Drangova M; Holdsworth DW
    Med Phys; 2008 Nov; 35(11):5030-42. PubMed ID: 19070237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A perfusion procedure for imaging of the mouse cerebral vasculature by X-ray micro-CT.
    Ghanavati S; Yu LX; Lerch JP; Sled JG
    J Neurosci Methods; 2014 Jan; 221():70-7. PubMed ID: 24056228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in ytterbium-based contrast agents for in vivo X-ray computed tomography imaging: promises and prospects.
    Liu Y; Liu J; Ai K; Yuan Q; Lu L
    Contrast Media Mol Imaging; 2014; 9(1):26-36. PubMed ID: 24470292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assessment of poly-iodinated triglyceride reconstituted low-density lipoprotein: initial steps toward CT molecular imaging.
    Hill ML; Corbin IR; Levitin RB; Cao W; Mainprize JG; Yaffe MJ; Zheng G
    Acad Radiol; 2010 Nov; 17(11):1359-65. PubMed ID: 20719547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular imaging with contrast agent in hard and soft tissues using microcomputed-tomography.
    Blery P; Pilet P; Bossche AV; Thery A; Guicheux J; Amouriq Y; Espitalier F; Mathieu N; Weiss P
    J Microsc; 2016 Apr; 262(1):40-9. PubMed ID: 27002484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging in small animals--roles for micro-CT.
    Ritman EL
    J Cell Biochem Suppl; 2002; 39():116-24. PubMed ID: 12552611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.